Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
NPC Blog
NPC Blog
2008 Archives
2007 Archives
2006 Archives
Search Archives
Archives
  • October 2008 (1)
  • September 2008 (1)
  • August 2008 (2)
  • July 2008 (2)
  • June 2008 (4)
  • May 2008 (1)
  • April 2008 (1)
  • March 2008 (4)
  • February 2008 (1)
  • April 2007 (1)
  • December 2006 (1)
  • October 2006 (1)
  • September 2006 (1)
  • July 2006 (2)
  • June 2006 (3)
  • Blog Updates
    Signup here and receive blog posts directly in your inbox.

     

    Subscribe in a reader

     
    E-Alerts
    Signup to receive news and announcements from Nutra Pharma
    Name:
    Email:

    Yes, in addition to e-alerts, please sign me up to receive Nutra Pharma Blog postings via email.

     
    Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

    NPC Blog

    Archive for June, 2008

    Nontuberculous Mycobacteria, also known as atypical mycobacteria and mycobacteria other than tuberculosis (MOTT), is bacteria that most of us have never head of, yet it’s one of the primary causes of respiratory diseases in humans and a leading cause of death in HIV patients. Additionally, many believe that one type of NTM, paratuberculosis, which can […]

    Read Full Post »

     

    Often times, when I tell people that I work for a biotech company developing a treatment for Multiple Sclerosis (MS) using cobra venom, I receive the strangest feedback.
    I agree that at first-glance cobras may seem an unlikely source for treating anything, but when one digs deeper, it become apparent that snakes may hold the key […]

    Read Full Post »

     

    Next »

     
    Quick Nav
     
    Recent News
    November 17, 2008
    Nutra Pharma Announces Provision of RPI-78M under Compassionate Release to Adrenomyeloneuropathy (AMN) Patients


    August 14, 2008
    Nutra Pharma Announces Initial Positive Safety Data from Clinical Study in Adrenomyeloneuropathy (AMN)


    August 6, 2008
    Nutra Pharma Announces Collaborative Agreement with Centers for Disease Control and Prevention (CDC)


     
     
    Announcements
    Click Here for an Update on the Phase IIb Clinical Trial Data.
     
     
    NPC
    Privacy Policy